+45 50 20 60 71 
+1 209 213 2250follow our
weekly journal
Compassion, social return on investment via a global, thought provoking social return.
An Overview of Alzheimer’s Disease
Introduction Alzheimer’s disease is a serious medical condition that affects millions of people worldwide. It is the most common form of dementia, and it can cause long-term memory loss, cognitive decline, and behavioural changes. But what exactly is Alzheimer’s? How […]
OptoCeutics is Presenting at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022)
[vc_row][vc_column][vc_column_text]Copenhagen, Denmark, 24 November 2022 – OptoCeutics ApS (”OptoCeutics” or ”The Company”) is pleased to inform that they will be presenting at the 15 TH Clinical Trial on Alzheimer’s Disease NOVEMBER 29- DECEMBER 2, 2022 (“CTAD 2022”). OptoCeutics has successfully […]
OptoCeutics Launches ALZLIGHT Stage III Clinical Trial
[vc_row][vc_column][vc_column_text] Study on the Effect of 40 Hz Non-Invasive Light Therapy System [/vc_column_text][vc_column_text] The ALZLIGHT STAGE III Study is a continuation of the ALZLIGHT Pilot – Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System. As with […]
Natural Brainwaves: A Novel Therapeutic Target to Restore Brain Health
[vc_row thb_full_width=”true” css=”.vc_custom_1626870929996{padding-top: 3vh !important;padding-right: 3vh !important;padding-bottom: 3vh !important;padding-left: 3vh !important;}”][vc_column][vc_column_text] ❚ Brain Waves Brain waves are electrical impulses in the brain. They are at the root of all our behaviors, emotions, and thoughts. When the brain is working, the […]
What Happens When Your Brain Network Fails?
[vc_row thb_full_width=”true” css=”.vc_custom_1621414225470{padding: 3vh !important;}”][vc_column][vc_column_text] ❚ Brain Networks The brain is an astonishing and complex organ that shapes the way we think, feel, learn, communicate, and behave, but how does something that weighs only about three pounds do so much? […]
We have delivered 26 devices to Zealand University Hospital
[vc_row][vc_column][vc_column_text]OptoCeutics is pleased to announce the delivery of 26 devices to Zealand University Hospital for the continuation of our ALZLIGHT pilot clinical trial. Thank you to our amazing team who have worked tirelessly to make this happen! (ClinicalTrials.gov ID: NCT04574921). […]
We have started our clinical study for Alzheimer’s
[vc_row][vc_column][vc_column_text] Study on Safety, Feasibility and Neural Activation of Non-Invasive Light Therapy System [/vc_column_text][vc_column_text] Recent studies in mice have shown promising results indicating that induction of gamma oscillation at 40 Hz leads to a reduction in amyloid-β an tau in […]
We are happy to announce our participation in the EU-funded Astrotech Project
[vc_row][vc_column][vc_column_text] This grant will enable OptoCeutics to hire two PhD candidates to conduct research in collaboration with partnering institutions. The project itself will create and develop innovative technologies to study the behavior of glial cells in cognitive functions and in […]
TV2 Lorry
[vc_row][vc_column][vc_column_text] TV2 Lorry has followed us for a long time in connection with our participation in the Danish Tech Challenge. We are very pleased with the great media coverage we have been given, so that we can get more focus […]
